The effects of introducing a clinical pharmacist on orthopaedic wards in Denmark
- 251 Downloads
To assess the effects and cost effects of introducing clinical pharmacists on hospital wards.
Comparative prospective study on four orthopaedic surgical wards in two hospitals. The primary effect variables were 10 target areas widely considered to be indicators of good prescription practice. Prescriptions not following good practice in these intervention areas were defined as “sub-optimal prescriptions,” and then discussed between a physician and a clinical pharmacist. The primary parameter was the difference in the number of days with a sub-optimal prescription (Mann–Whitney test).
On an average 20% of all the patients had a sub-optimal prescription. Of these, 70% were changed by the physician after intervention by the clinical pharmacist. There was a statistically significant difference in the duration of days in treatment with a sub-optimal prescription. Where sub-optimal prescriptions were changed, 43% resulted in cost reductions. The reductions achieved could cover 47% of the costs of clinical pharmacy service.
Clinical pharmacy services offered to four orthopaedic surgical wards resulted in reduction of sub-optimal prescriptions. Every time the pharmacist screened seven patients one sub-optimal prescription was found and adjusted. The reduction in medicine costs due to adjusted sub-optimal prescriptions could not cover the whole cost of clinical pharmacy service.
KeywordsClinical pharmacy Clinical pharmacy service Clinical pharmacist Medical prescription Quality assessment
Unable to display preview. Download preview PDF.
- 1.The Danish Medicines Agency. http://www.produktresume.dk/docushare/dscgi/ds.py/Get/File-16986/Tabel_1.4. doc.. (20 okt. 2003)
- 4.Hallas J (1996). Drug related hospital admissions in subspecialities of internal medicine. Dan Med Bull 43: 6–8Google Scholar
- 5.Wiffen P, Gill M, Edwards J, Moore A. Adverse drug reactions in hospital patients. http://www.jr2.ox.ac.uk/bandolier/extraforbando/adrom.pdf.
- 7.Cotter SM, Barber ND and McKee M (1994). Survey of clinical pharmacy services in United Kingdom National Health Service Hospitals. Am J Hosp Pharm 51: 397–405Google Scholar
- 9.Navrbjerg PK and Zederkof S (1998). Rationel farmkoterapi på plejehjem. Månedsskr prakt lægegern 76: 563–569Google Scholar
- 11.Hatoum HT and Akhras K (1993). 32-year literature review on the value and acceptance of ambulatory care provided by pharmacists. Bioliography Ann Pharmacother 27: 1106–1119Google Scholar
- 12.Lægemiddelkataloget (The Danish National Formulary) (2001) ISBN: 0105-287XGoogle Scholar
- 15.Silverstein FE, Faich G and Geis GS (2000). Gastrointestinal toxicity with celecoxib vs. nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: a randomized controlled trial. Celecoxib long-term arthritis safety study. JAMA 284: 1247–1255CrossRefPubMedGoogle Scholar
- 16.Institute for Rational Pharmacotherapy. http://www.irf.dk/dk/publikationer/maanedsblad/nasid_-_oemme_punkter.htm.. (10 Aug. 2002)
- 17.Institute for Rational Pharmacotherapy. http://www.irf.dk/dk/praeparatnyt/arkiv/celecoxib_celebra_02.htm.. (10 Aug. 2002)
- 20.Eriksen J, Sjøgren P, Jensen NH (2000) Praktisk klinisk smertebehandling, pp. 56–139. ISBN 87-16-12296-8Google Scholar